During the past decade, University of South Alabama Medical Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 13 clinical trials were completed, i.e. on average, 108.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 8 clinical trials were completed. i.e. 266.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of South Alabama Medical Center" #1 sponsor was "Children's Oncology Group" with 12 trials, followed by "National Cancer Institute (NCI)" with 3 trials sponsored, "University of South Alabama" with 3 trials sponsored, "Eisai Inc." with 2 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of South Alabama Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "Biotec Services International Ltd" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "CBR International Corp." with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "University of South Alabama Medical Center" are "Burns" (5 trials), "Leukemia" (5 trials), "Atrial Fibrillation" (3 trials), "Brain and Central Nervous System Tumors" (3 trials) and "Lymphoma" (3 trials). Many other conditions were trialed in "University of South Alabama Medical Center" in a lesser frequency.

Most popular intervention types in "University of South Alabama Medical Center" are "Drug" (39 trials), "Biological" (8 trials), "Procedure" (6 trials), "Other" (4 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "cyclophosphamide" (5 trials), "filgrastim" (5 trials), "etoposide" (4 trials) and "Apixaban" (3 trials). Other intervention names were less common.

The vast majority of trials in "University of South Alabama Medical Center" are 46 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "University of South Alabama Medical Center". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in University of South Alabama Medical Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in University of South Alabama Medical Center, 6 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".

University of South Alabama Medical Center has several departments that took part in Clinical trials: "University of South Alabama Mitchell Cancer Institute" - 109 trials, "University of South Alabama Children's and Women's Hospital" - 13 trials